Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05794100 · ClinicalTrials.gov registry record · NA
Evaluating the Impact of Different Sugar Replacer Combinations on Gastrointestinal Tolerance
A NA study of Tolerance and Healthy Population, sponsored by Mondelēz International.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05794100: Completed NA study of Tolerance and Healthy Population, sponsored by Mondelēz International.
NCT05794100 is a NA study of Tolerance and Healthy Population that has completed, run by Mondelēz International. The registered enrollment target is 60 participants, above the 47-participant average among 7 other Tolerance trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05794100, a NA study of Tolerance and Healthy Population, has completed, sponsored by Mondelēz International.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized, double-blind, crossover trial aiming at evaluating the gastrointestinal tolerance of 3 sugar replacers mixes at 3 different doses. The investigators will also try to understand the factors that could explain the presence or absence of symptoms
Primary Outcome
AUC of the composite Gastrointestinal symptoms score based on GITQ (gastro-intestinal tolerance questionnaire)
Conditions Studied
Interventions
- OTHER Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator
Study Locations (1)
Illinois
- Biofortis Innovation Services - Addison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2022-07-30 |
| Phase | NA |
What the finished NCT05794100 record still lists
NCT05794100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, above the 47-participant average among 7 other Tolerance trials with a reported enrollment target (28% higher).
The record links to 2 conditions, with Tolerance appearing as the primary indexed condition, and to 1 intervention - of which Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator is the first listed.
NCT05794100 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05794100 about?
NCT05794100 is a clinical study titled "Evaluating the Impact of Different Sugar Replacer Combinations on Gastrointestinal Tolerance". This study is a randomized, double-blind, crossover trial aiming at evaluating the gastrointestinal tolerance of 3 sugar replacers mixes at 3 different doses. The investigators will also try to understand the factors that could explain the presence or absence of symptoms
What is the current status of trial NCT05794100?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-10-11. Estimated completion is 2022-07-30.
What conditions does trial NCT05794100 study?
This clinical trial studies the following conditions: Tolerance, Healthy Population.
What interventions are being tested in trial NCT05794100?
The interventions under investigation include: Acute intake of one of the products (active comparator 1 to 9) or Placebo comparator (OTHER).
Who is sponsoring clinical trial NCT05794100?
This trial is sponsored by Mondelēz International, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05794100 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tolerance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
RECRUITING · NA
-
Tolerance and Utilization of Agave Inulin in Healthy Adults
COMPLETED · NA
-
Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers
COMPLETED · NA
-
Buck Institute Ketone Ester RCT
COMPLETED · NA
-
Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
RECRUITING · Phase 1
-
Cannabis Tolerance Break Resource Study: T-Break Guide
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI